Chromatography resins market seen doubling by 2030

A new Allied Market Research report says the global chromatography resins market is set to grow from $2.1 billion in 2020 to $4.1 billion by 2030, fueled by biomolecule purification, vaccine manufacturing and advances in affinity and ion-exchange resins. North America led the market in 2020, while antibody purification and ion-exchange resins are among the fastest-moving segments.

Why it matters: - Chromatography resins are a core input for biomolecule separation, antibody purification and vaccine manufacturing. - The market’s projected rise to $4.1 billion by 2030 points to sustained demand across biopharma, research and industrial biotechnology. - Better purification efficiency and scalability can affect production speed, product quality and manufacturing costs.

What happened: - Allied Market Research projected the global chromatography resins market will grow from $2.1 billion in 2020 to $4.1 billion by 2030. - The forecast implies a 7.1% compound annual growth rate from 2021 to 2030. - The report covers resin types including hydrophobic interaction, multimodal or mixed-mode, size exclusion, affinity, ion-exchange and other resins. - The report also covers applications including antibody purification, biomolecule separation and purification, vaccination and other uses. - The source report is titled "Chromatography Resins Market by Type (Hydrophobic Interaction Resin, Multimodal or Mixed-Mode Resin, Size Exclusion Resin, Affinity Resin, Ion-Exchange Resin, and Others) and Application (Antibody Purification, Biomolecule Separation & Purification, Vaccination, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030." - A sample report page is available via Download Sample Pages of Research Overview.

The details: - Biomolecule separation and purification across the biopharmaceutical industry are a major demand driver. - Advances in affinity and ion-exchange chromatography resins are improving purification efficiency, scalability and product quality. - High production costs remain a challenge for chromatography resin makers. - Vaccine development and purification technologies are creating additional growth opportunities. - Affinity resins held the largest market share in 2020, with more than half of global revenue. - Affinity resins are favored for high binding capacity, selectivity for antibody fragments, minimal ligand leakage, faster purification and reduced resin consumption. - Ion-exchange resins are forecast to grow the fastest, at a 7.5% CAGR through 2030. - Demand for high-resolution protein separation, higher sample loading capacity and manufacturing flexibility is supporting ion-exchange growth. - Antibody purification accounted for more than one-third of global revenue in 2020. - Antibody purification is projected to post a 7.4% CAGR through 2030. - Antibody purification is supported by high-capacity purification, efficient handling of high-titer feedstocks, mild elution conditions and stronger overall purification performance. - North America led the global market in 2020 with more than one-third of total revenue. - North America is projected to grow at a 7.6% CAGR through 2030. - The region’s position is supported by a large base of chromatography resin manufacturers, growth in biotechnology and pharmaceutical companies, broad use of chromatography for analytical testing and product purification, and investment in life sciences research and bioprocessing. - The report also evaluates Europe, Asia-Pacific and LAMEA. - Major companies listed in the market include Cytiva Life Sciences, Sartorius AG, Bio-Rad Laboratories, Tosoh Bioscience, Generon, Repligen Corporation, Bio-Works, JNC Corporation, LAF Biotechnology and Anatrace Products.

Between the lines: - The forecast reflects a market tied closely to biologics manufacturing, where purification performance can directly affect output and quality. - The fastest-growing segments are the ones most aligned with higher-throughput protein processing and antibody production. - North America’s lead suggests the market is still concentrated around established bioprocessing ecosystems and supplier networks.

What's next: - Further investment in vaccine development and purification technologies is expected to keep demand rising. - Competition is likely to center on performance gains in selectivity, scalability and cost efficiency. - The report’s purchase page is available via Access the statistical data and graphs.